Literature DB >> 18250098

Activation of beta-catenin signaling by Rspo1 controls differentiation of the mammalian ovary.

Anne-Amandine Chassot1, Fariba Ranc, Elodie P Gregoire, Hermien L Roepers-Gajadien, Makoto M Taketo, Giovanna Camerino, Dirk G de Rooij, Andreas Schedl, Marie-Christine Chaboissier.   

Abstract

The sex of an individual is determined by the fate of the gonad. While the expression of Sry and Sox9 is sufficient to induce male development, we here show that female differentiation requires activation of the canonical beta-catenin signaling pathway. beta-catenin activation is controlled by Rspo1 in XX gonads and Rspo1 knockout mice show masculinized gonads. Molecular analyses demonstrate an absence of female-specific activation of Wnt4 and as a consequence XY-like vascularization and steroidogenesis. Moreover, germ cells of XX knockout embryos show changes in cellular adhesions and a failure to enter XX specific meiosis. Sex cords develop around birth, when Sox9 becomes strongly activated. Thus, a balance between Sox9 and beta-catenin activation determines the fate of the gonad, with Rspo1 acting as a crucial regulator of canonical beta-catenin signaling required for female development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18250098     DOI: 10.1093/hmg/ddn016

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  131 in total

Review 1.  A role for estrogen in somatic cell fate of the mammalian gonad.

Authors:  Andrew J Pask
Journal:  Chromosome Res       Date:  2012-01       Impact factor: 5.239

2.  Chromosomal assignment of R-spondin genes in the donkey (Equus asinus, 2n = 62).

Authors:  L De Lorenzi; V Genualdo; A Perucatti; G Pia Di Meo; L Molteni; L Iannuzzi; P Parma
Journal:  J Appl Genet       Date:  2010       Impact factor: 3.240

3.  Ectopic expression of mouse Sry interferes with Wnt/beta-catenin signaling in mouse embryonal carcinoma cell lines.

Authors:  Dana Ann A Tamashiro; Vernadeth B Alarcón; Yusuke Marikawa
Journal:  Biochim Biophys Acta       Date:  2008-07-14

4.  Genetic interactions of the androgen and Wnt/beta-catenin pathways for the masculinization of external genitalia.

Authors:  Shinichi Miyagawa; Yoshihiko Satoh; Ryuma Haraguchi; Kentaro Suzuki; Taisen Iguchi; Makoto M Taketo; Naomi Nakagata; Takahiro Matsumoto; Ken-ichi Takeyama; Shigeaki Kato; Gen Yamada
Journal:  Mol Endocrinol       Date:  2009-03-12

5.  Antagonism of the testis- and ovary-determining pathways during ovotestis development in mice.

Authors:  Dagmar Wilhelm; Linda L Washburn; Vy Truong; Marc Fellous; Eva M Eicher; Peter Koopman
Journal:  Mech Dev       Date:  2009-03-06       Impact factor: 1.882

6.  DMRT1 protects male gonadal cells from retinoid-dependent sexual transdifferentiation.

Authors:  Anna Minkina; Clinton K Matson; Robin E Lindeman; Norbert B Ghyselinck; Vivian J Bardwell; David Zarkower
Journal:  Dev Cell       Date:  2014-05-22       Impact factor: 12.270

7.  Dysregulation of WNT/CTNNB1 and PI3K/AKT signaling in testicular stromal cells causes granulosa cell tumor of the testis.

Authors:  Alexandre Boyer; Marilène Paquet; Marie-Noëlle Laguë; Louis Hermo; Derek Boerboom
Journal:  Carcinogenesis       Date:  2009-02-23       Impact factor: 4.944

8.  β-Catenin directs the transformation of testis Sertoli cells to ovarian granulosa-like cells by inducing Foxl2 expression.

Authors:  Yaqiong Li; Lianjun Zhang; Yuqiong Hu; Min Chen; Feng Han; Yan Qin; Min Chen; Xiuhong Cui; Shuguang Duo; Fuchou Tang; Fei Gao
Journal:  J Biol Chem       Date:  2017-09-12       Impact factor: 5.157

Review 9.  The biology of infertility: research advances and clinical challenges.

Authors:  Martin M Matzuk; Dolores J Lamb
Journal:  Nat Med       Date:  2008-11-06       Impact factor: 53.440

10.  Sex-specific roles of beta-catenin in mouse gonadal development.

Authors:  Chia-Feng Liu; Nathan Bingham; Keith Parker; Humphrey H-C Yao
Journal:  Hum Mol Genet       Date:  2008-11-03       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.